New export sourcing Orders of Rs. 856 Million from Giant Exim & Ravina International
Welcure Wins New? 856 Million Export-Sourcing Orders From Giant Exim & Ravina International - Reg-30 Disclosure
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Story so far
- Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of TheSecurities And Exchange Board Of India (Listing Obligations And Disclosure Requirements),Regulations, 2015.
- Statement Of Investor Grievances Under Regulation 13(3) Of SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015.
- Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Earlier from Welcure Drugs and Pharmaceuticals
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 27 2025
- Closure of Trading Window
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 18 2025
- Intimation Under Regulation 30 - Rs. 517 Crore Global Sourcing Mandate
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jun 17 2025
Later from Welcure Drugs and Pharmaceuticals
- Completion Of Export-Sourcing Orders Aggregating Rs. 299.91 Crores
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jul 08 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Jul 21 2025
- Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Under The Regulation 29 Of Securities AndExchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015.
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals